Skip to main content
Clinical Trials/NCT02819648
NCT02819648
Completed
Phase 4

The Effect of Preoperative Oral Administration of Prednisolone on Postoperative Pain in Patients With Symptomatic Irreversible Pulpitis: A Single Center Randomized Controlled Trial

Cairo University1 site in 1 country400 target enrollmentJune 2012
ConditionsPulpitis
InterventionsPrednisoloneControl

Overview

Phase
Phase 4
Intervention
Prednisolone
Conditions
Pulpitis
Sponsor
Cairo University
Enrollment
400
Locations
1
Primary Endpoint
Degree of postoperative pain using a visual analogue scale (VAS)
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

The aim of this single-center randomized, double-blind, placebo-controlled clinical trial is to assess the effect of preoperative, single, oral dose of prednisolone on postoperative pain and medication intake in patients with symptomatic, irreversible pulpitis in mandibular molars.

Detailed Description

Patients receive 40 mg prednisolone (two tablets Prednisolone 20 mg, Aventis Intercontinental, Paris, France); and group B (Control), where patients received two placebo tablets. All patients receive the assigned premedication 30 minutes before the administration of local anesthesia

Registry
clinicaltrials.gov
Start Date
June 2012
End Date
June 2016
Last Updated
9 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Ahmed Elkhadem

Lecturer

Cairo University

Eligibility Criteria

Inclusion Criteria

  • Systemically healthy patients, aged between 18-35 years, with mandibular molars with symptomatic irreversible pulpitis, radiographically-normal periapical area and no pain on biting or percussion.

Exclusion Criteria

  • Pregnant patients, patients with any known sensitivity or adverse reactions to any of the medications or materials used in this study, those who had used any analgesic medication during the preceding 6 hours before the treatment, those with unrestorable teeth or teeth with severe periodontal disease. Patients with active sites of pathosis in the area of injection were, also, excluded.

Arms & Interventions

Prednisolone

40 mg prednisolone (two tablets Prednisolone 20 mg, Aventis Intercontinental, Paris, France); administered 30 minutes before endodontic treatment

Intervention: Prednisolone

Control

Milk tablet administered 30 minutes before endodontic treatment

Intervention: Control

Outcomes

Primary Outcomes

Degree of postoperative pain using a visual analogue scale (VAS)

Time Frame: 24 hours

Measured using visual analogue scale (VAS). It is a 10 points scale from 0 to 10, where zero expresses no pain and 10 expresses severe pain

Secondary Outcomes

  • Intake of fake analgesic (sham) following endodontic treatment (Binary outcome)(24 hours)
  • Intake of true analgesic following endodontic treatment (Binary outcome)(24 h)

Study Sites (1)

Loading locations...

Similar Trials